Latest Capital Restructuring News

Eden Innovations is set to consolidate its shares and launch a $6.6 million entitlement offer to reduce debt and fund global expansion of its EdenCrete® and OptiBlend® products.

Thrive Tribe Technologies has announced a proposed 20, 1 share consolidation aimed at streamlining its capital structure, pending shareholder approval at the upcoming Extraordinary General Meeting.

Beacon Minerals Limited has announced plans for a significant 40-for-1 consolidation of its shares and options, pending shareholder approval in July 2025. This move aims to streamline the capital structure and adjust option exercise prices accordingly.

EVE Health Group has successfully passed all shareholder resolutions at its recent General Meeting, paving the way for its acquisition of Nextract Pty Ltd and announcing significant leadership changes.

Talius Group Limited has secured shareholder approval to consolidate its shares on a 10-for-1 basis, aiming to better align its capital structure with industry peers. The move affects all ordinary shares and performance rights, effective June 4, 2025.

Trinex Minerals is set to seek shareholder approval for a significant 127:1 share consolidation aimed at streamlining its capital structure and enhancing investor appeal. The move also adjusts options and performance rights accordingly.

Aldoro Resources has launched a strategic review of its non-core exploration assets following external interest, while reaffirming focus on its flagship Kameelburg project.

Askari Metals offers holders of expired AS2O options a priority issue of new options, while advancing due diligence on a promising Ethiopian gold project.

Aspen Group has launched a $74 million equity raising to reduce debt and capitalize on growth opportunities in affordable housing, maintaining its FY25 earnings guidance.

OpenLearning Limited has agreed to convert $2.12 million of debt owed to its largest shareholder, Education Centre of Australia (ECA), into equity at a 25% premium, increasing ECA’s ownership and strengthening the company’s balance sheet.

Oncosil Medical Ltd has announced a significant 400-for-1 security consolidation affecting shares, options, and performance rights, with shareholder approval scheduled for late May 2025.

AMA Group Limited reported a near doubling of its normalised EBITDA in 3Q25, successfully completed a key capital restructure, and upgraded its FY25 earnings guidance amid operational improvements and strategic acquisitions.